BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lázaro-Muñoz G, Conley JM, Davis AM, Prince AE, Cadigan RJ. Which Results to Return: Subjective Judgments in Selecting Medically Actionable Genes. Genet Test Mol Biomarkers 2017;21:184-94. [PMID: 28146641 DOI: 10.1089/gtmb.2016.0397] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Staunton C, Kösters M, Pramstaller PP, Mascalzoni D. Return of research results (RoRR) to the healthy CHRIS cohort: designing a policy with the participants. J Community Genet 2021. [PMID: 34241790 DOI: 10.1007/s12687-021-00536-1] [Reference Citation Analysis]
2 Conley JM, Prince AER, Davis AM, Cadigan J, Lazaro-Munoz G. Is Real-Time ELSI Realistic? AJOB Empir Bioeth 2020;11:134-44. [PMID: 32040382 DOI: 10.1080/23294515.2020.1722289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Walker A, Boyce A, Duggal P, Thio CL, Geller G. Genomics and Infectious Diseases: Expert Perspectives on Public Health Considerations regarding Actionability and Privacy. Ethics Hum Res 2020;42:30-40. [PMID: 32421947 DOI: 10.1002/eahr.500051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Schoot VV, Viellevoije SJ, Tammer F, Brunner HG, Arens Y, Yntema HG, Oerlemans AJM. The impact of unsolicited findings in clinical exome sequencing, a qualitative interview study. Eur J Hum Genet 2021;29:930-9. [PMID: 33637888 DOI: 10.1038/s41431-021-00834-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lázaro-Muñoz G, Farrell MS, Crowley JJ, Filmyer DM, Shaughnessy RA, Josiassen RC, Sullivan PF. Improved ethical guidance for the return of results from psychiatric genomics research. Mol Psychiatry 2018;23:15-23. [PMID: 29158581 DOI: 10.1038/mp.2017.228] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
6 Kostick KM, Brannan C, Pereira S, Lázaro-Muñoz G. Psychiatric genetics researchers' views on offering return of results to individual participants. Am J Med Genet B Neuropsychiatr Genet 2019;180:589-600. [PMID: 30358063 DOI: 10.1002/ajmg.b.32682] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
7 Waltz M, Cadigan RJ, Prince AER, Skinner D, Henderson GE. Age and perceived risks and benefits of preventive genomic screening. Genet Med 2018;20:1038-44. [PMID: 29215654 DOI: 10.1038/gim.2017.206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Webber EM, Hunter JE, Biesecker LG, Buchanan AH, Clarke EV, Currey E, Dagan-Rosenfeld O, Lee K, Lindor NM, Martin CL, Milosavljevic A, Mittendorf KF, Muessig KR, O'Daniel JM, Patel RY, Ramos EM, Rego S, Slavotinek AM, Sobriera NLM, Weaver MA, Williams MS, Evans JP, Goddard KAB; ClinGen Resource. Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group. Hum Mutat 2018;39:1677-85. [PMID: 30311382 DOI: 10.1002/humu.23631] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
9 Shickh S, Clausen M, Mighton C, Gutierrez Salazar M, Zakoor KR, Kodida R, Reble E, Elser C, Eisen A, Panchal S, Aronson M, Graham T, Armel SR, Morel CF, Fattouh R, Glogowski E, Schrader KA, Hamilton JG, Offit K, Robson M, Carroll JC, Isaranuwatchai W, Kim RH, Lerner-Ellis J, Thorpe KE, Laupacis A, Bombard Y; Incidental Genomics Study Team. Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial. BMJ Open 2019;9:e031092. [PMID: 31594892 DOI: 10.1136/bmjopen-2019-031092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 Bradbury AR, Patrick-Miller L, Egleston BL, Maxwell KN, DiGiovanni L, Brower J, Fetzer D, Bennett Gaieski J, Brandt A, McKenna D, Long J, Powers J, Stopfer JE, Nathanson KL, Domchek SM. Returning Individual Genetic Research Results to Research Participants: Uptake and Outcomes Among Patients With Breast Cancer. JCO Precis Oncol 2018;2. [PMID: 32095738 DOI: 10.1200/po.17.00250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
11 Cadigan RJ, Butterfield R, Rini C, Waltz M, Kuczynski KJ, Muessig K, Goddard KAB, Henderson GE. Online Education and e-Consent for GeneScreen, a Preventive Genomic Screening Study. Public Health Genomics 2017;20:235-46. [PMID: 29069655 DOI: 10.1159/000481359] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
12 Owens K. The passivists: Managing risk through institutionalized ignorance in genomic medicine. Soc Sci Med 2022;294:114715. [PMID: 35033797 DOI: 10.1016/j.socscimed.2022.114715] [Reference Citation Analysis]
13 Saelaert M, Mertes H, De Baere E, Devisch I. Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate. Eur J Hum Genet 2018;26:1424-31. [PMID: 29970927 DOI: 10.1038/s41431-018-0200-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]